Pigment Cell & Melanoma Research, Volume 32, Issue 6Pages: i, 739-865 November 2019 |
COVER IMAGE
ISSUE INFORMATION
REVIEW
ORIGINAL ARTICLES
SHORT COMMUNICATIONS
LETTER TO THE EDITOR
ISSUE INFORMATION
REVIEW
Neuroblastoma rat sarcoma mutated melanoma: That’s what we got so far
Elisa Bertoli, Marco Giavarra, Maria Grazia Vitale, Alessandro Marco Minisini
Pages: 744-752 | First Published: 12 August 2019
The TYRP1‐mediated protection of human tyrosinase activity does not involve stable interactions of tyrosinase domains
Monika B. Dolinska, Paul T. Wingfield, Kenneth L. Young II, Yuri V. Sergeev
Pages: 753-765 | First Published: 11 May 2019
Tyrosinase‐catalyzed oxidation of resveratrol produces a highly reactive ortho‐quinone: Implications for melanocyte toxicity
Shosuke Ito, Yui Fujiki, Nina Matsui, Makoto Ojika, Kazumasa Wakamatsu
Pages: 766-776 | First Published: 02 July 2019
Role of melanoma inhibitory activity in melanocyte senescence
Lena Feuerer, Susanne Lamm, Ingmar Henz, Melanie Kappelmann‐Fenzl, Sebastian Haferkamp, Svenja Meierjohann, Claus Hellerbrand, Silke Kuphal, Anja Katrin Bosserhoff
Pages: 777-791 | First Published: 06 June 2019
Open Access
MITF controls the TCA cycle to modulate the melanoma hypoxia response
Pakavarin Louphrasitthiphol, Ioanna Ledaki, Jagat Chauhan, Paola Falletta, Robert Siddaway, Francesca M. Buffa, David R. Mole, Tomoyoshi Soga, Colin R. Goding
Pages: 792-808 | First Published: 17 June 2019
A novel LC‐MS/MS method to quantify eumelanin and pheomelanin and their relation to UVR sensitivity – A study on human skin biopsies
Catharina Margrethe Lerche, Peter Olsen, Christoffer Valdemar Nissen, Peter Alshede Philipsen, Hans Christian Wulf
Pages: 809-816 | First Published: 24 June 2019
Loss‐of‐function mutations in the melanocortin 1 receptor cause disruption of dorso‐ventral countershading in teleost fish
Laura Cal, Paula Suarez‐Bregua, Ingo Braasch, Uwe Irion, Robert Kelsh, Jose Miguel Cerdá‐Reverter, Josep Rotllant
Pages: 817-828 | First Published: 28 June 2019
C57BL/6 congenic mouse NRASQ61K melanoma cell lines are highly sensitive to the combination of Mek and Akt inhibitors in vitro and in vivo
Valérie Petit, Jeremy Raymond, Christophe Alberti, Marie Pouteaux, Stuart J. Gallagher, Mai Q. Nguyen, Andrew E. Aplin, Véronique Delmas, Lionel Larue
Pages: 829-841 | First Published: 28 June 2019
IL‐17A is not a treatment target in progressive vitiligo
Reinhart Speeckaert, Sofie Mylle, Nanja van Geel
Pages: 842-847 | First Published: 07 May 2019
NGS‐based targeted resequencing identified rare subtypes of albinism: Providing accurate molecular diagnosis for Japanese patients with albinism
Ken Okamura, Masahiro Hayashi, Yuko Abe, Michihiro Kono, Kimiko Nakajima, Yumi Aoyama, Chikako Nishigori, Hiroshi Ishimoto, Yuji Ishimatsu, Mika Nakajima, Yutaka Hozumi, Tamio Suzuki
Pages: 848-853 | First Published: 29 May 2019
Germline variants in oculocutaneous albinism genes and predisposition to familial cutaneous melanoma
Vaishnavi Nathan, Peter A. Johansson, Jane M. Palmer, Madeleine Howlie, Hayley R. Hamilton, Karin Wadt, Göran Jönsson, Kelly M. Brooks, Antonia L. Pritchard, Nicholas K. Hayward
Pages: 854-863 | First Published: 24 June 2019
Excimer stamp test distinguishing between nevus depigmentosus and segmental vitiligo
Jung Min Bae, Sung Hye Eun, Yeong Ho Kim, Ji Hun Park, Seung‐Kyung Hann
Pages: 864-865 | First Published: 31 July 2019
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου